Science 37 Holdings, Inc. (SNCE)
Science 37 Holdings, Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Research Triangle Park, NC, US. The stock last traded at $5.75, up 0.35% on the session, giving a market capitalisation of $34.7M. On trailing twelve-month figures it carries a trailing P/E of -13.07, a net margin of -72.7%. Its beta of 0.56 implies it has historically moved less than the broad market.
Science 37 Holdings, Inc. specializes in providing innovative technology solutions to enable flexible and decentralized clinical trials. Their central platform facilitates modern, digital approaches to clinical research by bringing together all essential parties—including patients, trial investigators, nurses, coordinators, and sponsors—to streamline processes, centralize data generation, and standardize information. Furthermore, the platform integrates specialized networks of patient communities, telemedicine-enabled investigators, mobile nursing professionals, remote coordinators, and connected health devices, all vital for orchestrating adaptable clinical studies. Its highly configurable nature means it can support nearly any phase of a clinical study and a wide range of medical indications. Beyond its direct services, the company also licenses its proprietary, cloud-based technology platform to various life science institutions. Science 37 serves a diverse client base, including major and mid-sized pharmaceutical companies, Contract Research Organizations (CROs), academic institutions, and biotechnology firms. Established in 2014, Science 37 Holdings, Inc. is headquartered in Research Triangle Park, North Carolina.
Science 37 Holdings, Inc. is most often compared with the following Healthcare names: